Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28606531 | 0.86 | APP (0.46) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL4744742 | 0.83 | S1PR2 (0.44) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL7639998 | 0.80 | LMNA (0.42) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL999249 | 0.80 | LMNA (0.48) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL7621164 | 0.79 | S1PR2 (0.45) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL7436774 | 0.78 | PMP22 (0.38) | S1PR2S1PR1S1PR3ENPEPTP53 | |
| SCHEMBL29180212 | 0.78 | PMP22 (0.38) | S1PR2S1PR1S1PR3ENPEPTP53 | |
| Ec33 SCHEMBL2310959 | 0.78 | ENPEP (0.59) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| SCHEMBL820427 | 0.78 | LMNA (0.52) | LMNASLC6A6CYP2C19BLMS1PR2 | |
| Ec33 SCHEMBL1291100 | 0.78 | ENPEP (0.59) | LMNASLC6A6CYP2C19BLMS1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112255395-A | Method for eliminating chyle interference in lipemic sample, immunoturbidimetry kit and application | 中生北控生物科技股份有限公司 | 2021-01-22 | — | — | CN | claimed |
| CN-112255395-B | Method for eliminating chyle interference in lipemic sample, immunoturbidimetry kit and application | 中生北控生物科技股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-112255395-A | Method for eliminating chyle interference in lipemic sample, immunoturbidimetry kit and application | 中生北控生物科技股份有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-1317539-A2 | DIRECTED EVOLUTION METHOD | MEDICAL RESEARCH COUNCIL (GB) | 2003-06-11 | — | — | EP | disclosed |
| WO-2002022869-A2 | DIRECTED EVOLUTION METHOD | MEDICAL RESEARCH COUNCIL (GB) | 2002-03-21 | — | — | WO | disclosed |